Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
出版年份 2020 全文链接
标题
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-12-02
DOI
10.3389/fonc.2020.580112
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
- (2020) Zheng Wang et al. Frontiers in Oncology
- Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study
- (2019) Kang Wang et al. EJSO
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Subdivision of M1 Stage for De Novo Metastatic Breast Cancer to Better Predict Prognosis and Response to Primary Tumor Surgery
- (2019) Caijin Lin et al. Journal of the National Comprehensive Cancer Network
- Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01
- (2018) Atilla Soran et al. ANNALS OF SURGICAL ONCOLOGY
- Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor–Positive Metastatic Breast Cancer: ALTERNATIVE
- (2018) Stephen R.D. Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study
- (2018) Luca Gianni et al. LANCET ONCOLOGY
- Bone metastasis pattern in initial metastatic breast cancer: a population-based study
- (2018) Zhenchong Xiong et al. Cancer Management and Research
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- First-Line Trastuzumab Plus an Aromatase Inhibitor, With or Without Pertuzumab, in Human Epidermal Growth Factor Receptor 2–Positive and Hormone Receptor–Positive Metastatic or Locally Advanced Breast Cancer (PERTAIN): A Randomized, Open-Label Phase II Trial
- (2018) Mothaffar Rimawi et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis
- (2018) Elvire Pons-Tostivint et al. ANNALS OF SURGICAL ONCOLOGY
- Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
- (2018) Weikai Xiao et al. Cancer Management and Research
- Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer – Results from the prospective German Tumour Registry Breast Cancer cohort study
- (2017) Jan Schröder et al. EUROPEAN JOURNAL OF CANCER
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
- (2017) Véronique Diéras et al. LANCET ONCOLOGY
- Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study
- (2017) Yue Gong et al. Scientific Reports
- Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study
- (2016) Anne Gulbech Ording et al. CLINICAL & EXPERIMENTAL METASTASIS
- Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer
- (2016) Michael Robert Mancuso et al. CURRENT PROBLEMS IN CANCER
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pattern of metastasis and outcome in patients with breast cancer
- (2015) L. Gerratana et al. CLINICAL & EXPERIMENTAL METASTASIS
- Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial
- (2015) Rajendra Badwe et al. LANCET ONCOLOGY
- Precision medicine for metastatic breast cancer—limitations and solutions
- (2015) Monica Arnedos et al. Nature Reviews Clinical Oncology
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- Primary Tumor Extirpation in Breast Cancer Patients Who Present with Stage IV Disease is Associated with Improved Survival
- (2013) Julie E. Lang et al. ANNALS OF SURGICAL ONCOLOGY
- Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
- (2013) Dorien J. A. Lobbezoo et al. BREAST CANCER RESEARCH AND TREATMENT
- Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
- (2013) Sandra M Swain et al. LANCET ONCOLOGY
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Does primary tumor resection improve outcomes for patients with incurable advanced breast cancer?
- (2011) Susumu Shibasaki et al. BREAST
- Impact of breast surgery on survival in women presenting with metastatic breast cancer
- (2011) N. Bhoo Pathy et al. BRITISH JOURNAL OF SURGERY
- Surgery in metastatic breast cancer: Patients with a favorable profile seem to have the most benefit from surgery
- (2011) Z.M. Rashaan et al. EJSO
- Stage IV breast cancer in the era of targeted therapy
- (2010) Heather B. Neuman et al. CANCER
- Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis
- (2009) J. Ruiterkamp et al. EJSO
- Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) José Baselga et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
- Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
- (2008) D Kay Blanchard et al. ANNALS OF SURGERY
- Matched Pair Analyses of Stage IV Breast Cancer with or Without Resection of Primary Breast Site
- (2008) B. Cady et al. ANNALS OF SURGICAL ONCOLOGY
- Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
- (2008) Grazia Arpino et al. ENDOCRINE REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started